Rocket Pharmaceuticals
Tracked across 2 events · 32 articles · First seen Jun 12, 2025 · Last active Aug 07, 2025
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Rocket Pharmaceuticals is facing a class action lawsuit for allegedly making misleading statements and concealing material adverse facts regarding the safety and clinical trial protocol of its RP-A501 drug, leading to a significant drop in its stock price.
Jun 12, 2025 · 26 articles
Business
Impact: Rocket Pharmaceuticals is facing a class action lawsuit for allegedly making false and misleading statements regarding its RP-A501 Phase 2 trial, which led to a clinical hold and a patient's death. This event has negatively impacted its stock price and reputation.
Jun 12, 2025 · 6 articles
NEWSDESK
Track Rocket Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard